Your AI-Powered Market Intelligence

Monday, July 27, 2026
RSS

Technology

Tempus AI's Acquisition of Personalis: A Significant Move in AI-Driven Cancer Detection

Tempus AI's strategic acquisition of Personalis may reshape the landscape of AI-driven cancer detection.

By Diana Kowalski • July 20, 2026
Economy

US Treasury Yields Rise Amid Middle East Tensions: What Investors Should Know

As tensions in the Middle East escalate, U.S. Treasury yields are reacting. Here’s what investors need to consider.

Marcus Rivera • Jul 20
Markets

Galaxy Gaming’s Merger Uncertainty: What It Means for Investors Following Regulatory Hurdles

Galaxy Gaming's merger with Evolution Malta faces uncertainty after missing regulatory deadlines, raising questions for shareholders.

Theo Marchetti • Jul 20
Trade with the conviction of the 1%.

Institutional-grade market intelligence delivered before the opening bell.

By subscribing, I agree to receive marketing emails and alerts. View our Privacy Policy. You may unsubscribe at any time.

More Stories
Markets

Brookfield and CPP Investments Complete $5.2B Acquisition of LXP Industrial Trust: Implications for Investors

Brookfield and CPP Investments have acquired LXP Industrial Trust for $5.2 billion, paying shareholders $61.20 per share…

James McAllister • Jul 20, 2026
Economy

US Consumer Sentiment Surges, Easing Inflation Fears: What It Means for Investors

Consumer sentiment jumps to 54.4, signaling optimism and potential impacts on inflation and equities.

Marcus Rivera • Jul 17, 2026
Earnings

Fifth Third Bancorp's Q2 Earnings Boosted by Comerica Acquisition: A Positive Sign for Regional Banks

Fifth Third Bancorp's Q2 earnings surge, fueled by the Comerica acquisition, signals optimism for regional banks amid ma…

Theo Marchetti • Jul 17, 2026
Analysis

Tech Sector Struggles Amid Chip Stocks Sell-Off: Insights for Investors

The tech sector faces headwinds as chip stocks drag down the Nasdaq, despite solid results from TSM.

James McAllister • Jul 17, 2026
Analysis

Merck's Interest in Personalis: A Game-Changer for Cancer Genomics?

Merck's potential acquisition of Personalis could reshape the oncology landscape and investor strategies in biotech.

Catherine Walsh • Jul 17, 2026
IPO

Glucotrack and Lōkahi Therapeutics: A New Era Post-Business Combination

Glucotrack (GCTK) and Lōkahi Therapeutics are entering a new chapter with strategic financing support from E.F. Hutton.

Tyler Brooks • Jul 17, 2026
Technology

Electronic Arts Acquisition: What EU Approval Means for Investors

Saudi Arabia's PIF is nearing EU approval for the EA acquisition, a significant move for gaming investors.

Diana Kowalski • Jul 17, 2026
Markets

Gold Resource Corp's Merger: What Exclusion from Russell 2000 Means for Investors

Gold Resource Corp's merger with Goldgroup Mining raises concerns over Russell 2000 exclusion and its implications for i…

Marcus Rivera • Jul 17, 2026
Earnings

Fifth Third Bancorp's Q2 Surge: What Investors Need to Know

Fifth Third Bancorp's stock gains traction following a successful acquisition, highlighting M&A's role in regional banki…

Theo Marchetti • Jul 17, 2026